Amarin Calls Pop After Big FDA Ruling

Amarin Calls Pop After Big FDA Ruling

The shares of Amarin Corporation (NASDAQ:AMRN) are up 1.9% to trade at $24.57, after the Food and Drug Administration (FDA) approved Vascepa — the drugmaker’s fish-oil derived treatment for heart …